Nuvalent Inc (NUVL)
99.10
-1.95
(-1.93%)
USD |
NASDAQ |
Sep 27, 16:00
99.01
-0.09
(-0.09%)
After-Hours: 20:00
Nuvalent Cash from Financing (Quarterly): 4.137M for June 30, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 4.137M |
| March 31, 2024 | 5.986M |
| December 31, 2023 | 333.42M |
| September 30, 2023 | 2.143M |
| June 30, 2023 | 1.298M |
| March 31, 2023 | -0.017M |
| December 31, 2022 | 248.67M |
| September 30, 2022 | 1.006M |
| June 30, 2022 | 0.005M |
| Date | Value |
|---|---|
| March 31, 2022 | -0.768M |
| December 31, 2021 | -0.944M |
| September 30, 2021 | 174.93M |
| June 30, 2021 | 134.23M |
| March 31, 2021 | 10.00M |
| December 31, 2020 | 0.015M |
| September 30, 2020 | 10.00M |
| June 30, 2020 | -0.25M |
| March 31, 2020 | 12.50M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-0.944M
Minimum
Dec 2021
333.42M
Maximum
Dec 2023
52.02M
Average
3.14M
Median
Cash from Financing (Quarterly) Benchmarks
| Bristol-Myers Squibb Co | -4.023B |
| Replimune Group Inc | 96.64M |
| Moderna Inc | 34.00M |
| NovaBay Pharmaceuticals Inc | -0.492M |
| Palatin Technologies Inc | 9.136M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -41.16M |
| Cash from Investing (Quarterly) | 16.21M |
| Free Cash Flow | -130.44M |
| Free Cash Flow Per Share (Quarterly) | -0.6371 |
| Free Cash Flow Yield | -2.12% |